Skip to content

Feed Screener MCP Methodology

⌘K

EN

Pricing Sign in

InsiderLens

Public insider filings, with historical context.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
AMF · FR
BAFIN · DE

Product

Recent insider buying
Cluster buys
How to read a Form 4
Ask the record
Help
About InsiderLens
Methodology
Signal backtests
Terms
Privacy notice
Object to processing

Language

English Español Français

Equal Talent Investments Ltd — Kezar Life Sciences, Inc. insider: 1 transactions · InsiderLens

Feed Screener MCP Methodology

Pricing Sign in

English Español Français

/ / Equal Talent Investments Ltd

Equal Talent Investments Ltd

FollowCreate a free account to set a filing alert.

10% owner at Kezar Life Sciences, Inc. · on record since Feb 6, 2020

Insider trading activity of Equal Talent Investments Ltd

Transactions on record: 1; since Jun 15, 2020

Purchases: 1; $8M

Sales: 0

Companies traded: 1; last filing Jun 15, 2020

Figures computed from official regulatory filings — .

Companies where Equal Talent Investments Ltd has traded

Kezar Life Sciences, Inc.1 tx · $8M · Jun 15, 2020

Track record of Equal Talent Investments Ltd

Insufficient history for a statistical track record (fewer than 5 purchases).

Transaction history of Equal Talent Investments Ltd

Co-insiders of Equal Talent Investments Ltd

Aberdare Management Company, LLCKezar Life Sciences, Inc.
AMGEN INCKezar Life Sciences, Inc.
AMP&A Management V, LLCKezar Life Sciences, Inc.
A.M. Pappas & Associates, LLCKezar Life Sciences, Inc.
A.M. Pappas Life Science Ventures V, LPKezar Life Sciences, Inc.
BAY CITY CAPITAL LLCKezar Life Sciences, Inc.
Belsky MarcKezar Life Sciences, Inc.
BERGER FRANKLIN MKezar Life Sciences, Inc.
Chen BihuaKezar Life Sciences, Inc.
Chiang Pichi LuoKezar Life Sciences, Inc.
Chiesi GiacomoKezar Life Sciences, Inc.
Chiesi Ventures, Inc.Kezar Life Sciences, Inc.
Chiesi Ventures, LPKezar Life Sciences, Inc.
COOPER GRAHAM KKezar Life Sciences, Inc.
Cormorant Asset Management, LPKezar Life Sciences, Inc.
Cormorant Global Healthcare GP, LLCKezar Life Sciences, Inc.
Cormorant Global Healthcare Master Fund, LPKezar Life Sciences, Inc.
CORMORANT PRIVATE HEALTHCARE FUND I, LPKezar Life Sciences, Inc.
Dinges JasonKezar Life Sciences, Inc.
Economides VassilikiKezar Life Sciences, Inc.
Fowler John FranklinKezar Life Sciences, Inc.
Garner ElizabethKezar Life Sciences, Inc.
Goel NitiKezar Life Sciences, Inc.
Henig NoreenKezar Life Sciences, Inc.
Kauffman MichaelKezar Life Sciences, Inc.
Kirk Christopher J.Kezar Life Sciences, Inc.
Klearman MickiKezar Life Sciences, Inc.
Lim Richard J.Kezar Life Sciences, Inc.
Mordwinkin Nicholas MichaelKezar Life Sciences, Inc.
Morningside Venture Investments LtdKezar Life Sciences, Inc.
Omega Fund IV GP, L.P.Kezar Life Sciences, Inc.

This page republishes public regulatory disclosures.

Omega Fund IV G.P. Manager, Ltd.Kezar Life Sciences, Inc.

Omega Fund IV, L.P.Kezar Life Sciences, Inc.

Onyx Therapeutics, Inc.Kezar Life Sciences, Inc.

PAPPAS ARTHUR MKezar Life Sciences, Inc.

Paster Anne-MariKezar Life Sciences, Inc.

PV V CEO Fund, LPKezar Life Sciences, Inc.

Schiller Mark C.Kezar Life Sciences, Inc.

Sommadossi Jean-PierreKezar Life Sciences, Inc.

Stampacchia OtelloKezar Life Sciences, Inc.

STEYER THOMAS FKezar Life Sciences, Inc.

To Zung PhoungKezar Life Sciences, Inc.

Wallace CourtneyKezar Life Sciences, Inc.

Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src	Details
Kezar Life Sciences, Inc.Security delisted	Jun 15, 2020	Buy	1,454,545	5.50 USD	$8M	conv 31First in 12mo	SEC